Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Regulating Lipid Droplet Interface Based on MFGM to Promote the Humanization of Infant Formula.

Created on 12 Aug 2026

Authors

Qipeng Niu, Ruida Ma, Yonglei He, Xuemei Zhu, Fang Qian

Published in

Journal of agricultural and food chemistry. Volume 74. Issue 31. Pages 24613-24627. Aug 12, 2026.

Abstract

To examine whether interfacial milk fat globule membrane (MFGM) remodeling improves lipid digestion and metabolism, three infant formulas (IFs) were developed referencing human milk (HM): IF1 (no exogenous MFGM supplementation), IF2 (wet-mixed MFGM), IF3 (dry-blended MFGM). Interface analysis confirmed IF1 droplets were coated with whey and casein; MFGM assembled on IF2 to restructure interfacial proteins and phospholipids, while most MFGM stayed dispersed in IF3's aqueous phase. In vitro digestion showed IF2 had HM-similar particle size and zeta potential trends, and its free fatty acid release was 58.34% higher than IF1 and 18.27% higher than IF3. Serum metabolomics found IF2's metabolic profile matched HM most closely. In cognitive tests, IF2 exhibited shorter escape latency and higher hippocampal BDNF and NeuN expression than IF1. Overall, interfacial MFGM rearrangement promotes lipid digestion and metabolism with improved spatial memory. The present findings lay a theoretical foundation for infant formula optimization, requiring further clinical validation.

PMID:
42584149
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement